eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on April 30, 2021. The report details the closing of a private placement transaction previously announced on February 17, 2021, involving the issuance of Series A Preferred Stock to an investment vehicle of H.I.G. Capital.
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, or margins. The primary financial event reported is the capital raise:
- Transaction Type: Private placement of Series A Preferred Stock.
- Shares Issued: 2,250,000 shares.
- Aggregate Purchase Price: $225,000,000.
- Investor: Echelon Health SPV, LP (an investment vehicle of H.I.G. Capital).
Material Changes
The material change reported is the completion of the equity financing and the associated corporate governance adjustments:
- Capital Structure: The Company designated and issued 2,250,000 shares of Series A Preferred Stock.
- Governance Waivers: To maintain the independence of the Company's auditors (Ernst & Young LLP) under Regulation S-X, the Investor executed a Waiver Letter. This waiver temporarily suspends specific rights granted in the Investment Agreement, including:
- The right to nominate one individual to the Board of Directors.
- The right to approve the annual budget or material deviations.
- The right to approve the hiring or firing of the CEO, CFO, Chief Digital Officer, or Chief Revenue Officer.
Outlook, Risks, and Contingencies
The filing contains forward-looking statements regarding the terms of the Investment Agreement and the Waiver Letter. The Company notes that actual results may differ due to market conditions and potential amendments to the agreement. The waiver of investor rights is contingent upon the resolution of auditor independence issues; rights will remain waived until Ernst & Young no longer has a conflicting business relationship, the Investor no longer controls the conflicting entity, or the auditor is replaced.
Investor Verification Checklist
- Verify the full text of the Certificate of Designations (Exhibit 3.1) to understand the specific rights and preferences of the Series A Preferred Stock.
- Review the February 18, 2021 Form 8-K for the complete summary of the Investment Agreement and the rights that were waived.
- Monitor future filings for updates on the status of the auditor independence issue and the potential reinstatement of the Investor's governance rights.
- Confirm the use of proceeds from the $225 million private placement in subsequent financial reports.